AIM Prospective Admission

RNS Number:7686H
AIM
20 February 2003

COMPANY NAME:
Interactivity Group plc, to be renamed Healthcare Enterprise Group PLC

COMPANY ADDRESS:
9th Floor, Winchester House, 259 Old Marylebone Road, London

COMPANY POSTCODE:
NW1 5RA

COUNTRY OF INCORPORATION:
England & Wales

COMPANY BUSINESS:
Holding company of healthcare corporate advisory group

DETAILS OF SECURITIES TO BE ADMITTED (i.e. where known, number of shares, nominal value and issue price):
1,373,226,336 ordinary shares of 0.1p each

CAPITAL TO BE RAISED ON ADMISSION:
#nil

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS:

Directors (resigning upon Admission)

Christopher Robin Akers - chairman

Rodger David Sargent ACA - finance director

Graham Anderson Perske - non-executive director

Proposed directors

Stuart Bruck - proposed executive chairman

Michael Kingman Low - proposed chief operating officer

Lyndon James Gaborit ACA - proposed finance director

Nicholas Owen Brigstocke - proposed non-executive director

Anthony Roger Moore - proposed non-executive director

Henry John Mark Tompkins - proposed non-executive director

PERSON(S) INTERESTED IN 3% OR MORE OF THE ISSUER'S CAPITAL, EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL
STATING WHETHER BEFORE OR AFTER ADMISSION:

Shareholder                                                % holding as at the date   % holding following
                                                             of this announcement       admission to AIM

C R Akers                                                            18.2%                    Nil
R D Sargent                                                          7.7%                     Nil
Pershing Keen Nominees PSL 991 ACCT                                  6.0%                     0.8%
Pershing Keen Nominees TYCLT ACCT                                    5.9%                     0.8%
R Warner                                                             5.5%                     0.7%
NCL (Nominees) Limited A/C 175344                                    4.3%                     0.6%
Banca IMI (Nominees) Ltd A/C IMIW                                    4.2%                     0.6%
Redmayne Nominees Limited A/C F23293G                                3.9%                     0.5%
Sacker Investments Limited                                           3.3%                     0.5%
LPMCC, LLC                                                            Nil                    41.7%
Medical Investment Group Holdings Limited                             Nil                    23.9%
European Life Science Investors Limited                               Nil                     9.1%

NAMES AND ADDRESSES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (G) OF THE AIM RULES.
N/A

ACCOUNTING REFERENCE DATE:
30 September, changing to 28 February following Admission

NAME AND ADDRESS OF NOMINATED ADVISER:
Corporate Synergy PLC

12 Nicholas Lane

London EC4N 7BN

NAME AND ADDRESS OF BROKER:
Seymour Pierce

29/30 Cornhill

London EC3V 3NF

DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT
THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES.
Norton Rose

Kempson House

Camomile Street

London EC3A 7AN

DATE OF NOTIFICATION:
20 February 2003

NEW/ UPDATE (see note):

NEW

LISTED APPLICANTS MUST ALSO COMPLETE THE FOLLOWING:

DETAILS OF THE APPLICANT'S STRATEGY FOLLOWING ADMISSION INCLUDING, IN THE CASE OF AN INVESTING COMPANY, DETAILS
OF ITS INVESTMENT STRATEGY
As per the admission document

A DESCRIPTION OF ANY SIGNIFICANT CHANGE IN FINANCIAL OR TRADING POSITION OF THE APPLICANT, WHICH HAS OCCURRED
SINCE THE END OF THE LAST FINANCIAL PERIOD FOR WHICH AUDITED STATEMENTS HAVE BEEN PUBLISHED OR AN APPROPRIATE
NEGATIVE STATEMENT
No significant change has occurred since the last financial period

A STATEMENT THAT THE DIRECTORS OF THE APPLICANT HAVE NO REASON TO BELIEVE THAT ITS WORKING CAPITAL WILL BE
INSUFFICIENT FOR AT LEAST TWELVE MONTHS FROM THE DATE OF ITS ADMISSION
The proposed directors of Healthcare Enterprise Group have no reason to believe that its working capital will be
insufficient for at least twelve months from the date of its admission

DETAILS OF ANY LOCK-IN ARRANGEMENTS PURSUANT TO RULE 7 OF THE AIM RULES.
At Admission, vendors of L&P-MCC, Inc. will be interested in 1,180,723,605 ordinary shares in aggregate,
representing approximately 86.0 per cent. of the enlarged issued share capital.

The Proposed Directors and certain employees and substantial shareholders, who will hold in aggregate
1,037,079,597 ordinary shares (75.5 per cent of the enlarged issued share capital), have undertaken not to sell
or dispose of, or agree to sell or dispose of, any of their ordinary shares at any time in the year following
Admission, and for a further year thereafter will only sell or dispose of any of their ordinary shares through
Seymour Pierce or the Company's broker from time to time.

The remaining vendors of L&P-MCC, Inc. who will hold in aggregate 143,644,008 ordinary shares (10.5 per cent. of
the enlarged issued share capital), have undertaken not to sell or dispose of, or agree to sell or dispose of,
any of their Ordinary Shares at any time in the six month period following Admission, and for a further six
months thereafter will only sell or dispose of any of their Ordinary Shares through Seymour Pierce or the
Company's broker from time to time.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

PAAPUUACPUPWGAU